Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
véase relación en anexo nafthidrofuril véase relación en anexo solución para transfusión parenteral
international non-proprietary name (inn) naftidrofuryl strength pharmaceutical form route of administration
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
3. no pueden emplearse modernas técnicas biométricas para demostrar la eficacia del nafthidrofuril.
therefore the applicant does not have the burden of proof to show efficacy in the revocation of a marketing authorisation; 2. that there has been either insufficient or no justification of alleged harmful effects of naftidrofuryl; 3. that modern biometric techniques cannot be used to prove the efficacy of naftidrofuryl.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
no está demostrada la eficacia de la transfusión parenteral de nafthidrofuril (200 mg / 10 ml) en el tratamiento de dolores residuales de pacientes con enfermedad oclusiva arterial periférica grave.
the efficacy of parenteral infusion of naftidrofuryl (200mg/ 10ml) in the treatment of rest pain in patients with severe peripheral arterial occlusive disease had not been proven.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
2. existen suficientes indicios de reacciones potencialmente adversas debidas al nafthidrofuril (cf. informe de evaluación cef/ 624/ 95 iii 3.2);
1. the burden of proof to show efficacy lies with the holder of the marketing authorisation and not, as claimed in the grounds of appeal, with the national competent authorities (see assessment report cpmp/ 624/ 95 iii 3.3); 2.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
el cef emitió su dictamen en la reunión celebrada los días 7 y 8 de junio de 1995, en el cual se estipulaba que debían retirarse las autorizaciones de comercialización del nafthidrofuril (dictamen e informe de evaluación cef/ 345/ 95 anexo al presente dictamen).
the committee for proprietary medicinal products adopted its opinion at its meeting of 7-8 june 1995, saying that marketing authorisations for naftidrofuryl should be withdrawn (opinion and assessment report cpmp/ 345/ 95 appended to this opinion).
Last Update: 2012-04-10
Usage Frequency: 2
Quality: